Velocity Pharmaceutical Holdings Llc - Net Worth and Insider Trading

Velocity Pharmaceutical Holdings Llc Net Worth

The estimated net worth of Velocity Pharmaceutical Holdings Llc is at least $16 Million dollars as of 2024-11-13. Velocity Pharmaceutical Holdings Llc is the 10% Owner of Altimmune Inc and owns about 1,687,250 shares of Altimmune Inc (ALT) stock worth over $16 Million. Details can be seen in Velocity Pharmaceutical Holdings Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Velocity Pharmaceutical Holdings Llc has not made any transactions after 2020-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Velocity Pharmaceutical Holdings Llc

Velocity Pharmaceutical Holdings Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Velocity Pharmaceutical Holdings Llc owns 1 companies in total, including Altimmune Inc (ALT) .

Click here to see the complete history of Velocity Pharmaceutical Holdings Llc’s form 4 insider trades.

Insider Ownership Summary of Velocity Pharmaceutical Holdings Llc

Ticker	Comapny	Transaction Date	Type of Owner
ALT	Altimmune Inc	2020-05-15	10 percent owner

Velocity Pharmaceutical Holdings Llc Latest Holdings Summary

Velocity Pharmaceutical Holdings Llc currently owns a total of 1 stock. Velocity Pharmaceutical Holdings Llc owns 1,687,250 shares of Altimmune Inc (ALT) as of May 15, 2020, with a value of $16 Million.

Latest Holdings of Velocity Pharmaceutical Holdings Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ALT	Altimmune Inc	2020-05-15	1,687,250	9.49	16,012,003

Holding Weightings of Velocity Pharmaceutical Holdings Llc

Velocity Pharmaceutical Holdings Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Velocity Pharmaceutical Holdings Llc has made a total of 1 transactions in Altimmune Inc (ALT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Altimmune Inc is the sale of 200,000 shares on May 15, 2020, which brought Velocity Pharmaceutical Holdings Llc around $958,000.

Insider Trading History of Velocity Pharmaceutical Holdings Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Velocity Pharmaceutical Holdings Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Velocity Pharmaceutical Holdings Llc Ownership Network

Ownership Network List of Velocity Pharmaceutical Holdings Llc

No Data

Ownership Network Relation of Velocity Pharmaceutical Holdings Llc

Velocity Pharmaceutical Holdings Llc Owned Company Details

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Velocity Pharmaceutical Holdings Llc is the 10 percent owner of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Velocity Pharmaceutical Holdings Llc made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 15,711 shares made by David Drutz ,

In summary, during the past 3 months, insiders sold 16,011 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 16,011 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 300 shares were bought by its insiders, resulting in a net sale of 15,711 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

Velocity Pharmaceutical Holdings Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Velocity Pharmaceutical Holdings Llc. You might contact Velocity Pharmaceutical Holdings Llc via mailing address: 400 Oyster Blvd., Suite 202, South San Francisco Ca 94080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.